NEUROMODULATION SPECIALISTS LIMITED - LONDON
Company Profile | Company Filings |
Overview
NEUROMODULATION SPECIALISTS LIMITED is a Private Limited Company from LONDON UNITED KINGDOM and has the status: Active.
NEUROMODULATION SPECIALISTS LIMITED was incorporated 4 years ago on 23/12/2019 and has the registered number: 12374929. The accounts status is MICRO ENTITY and accounts are next due on 30/09/2024.
NEUROMODULATION SPECIALISTS LIMITED was incorporated 4 years ago on 23/12/2019 and has the registered number: 12374929. The accounts status is MICRO ENTITY and accounts are next due on 30/09/2024.
NEUROMODULATION SPECIALISTS LIMITED - LONDON
This company is listed in the following categories:
26600 - Manufacture of irradiation, electromedical and electrotherapeutic equipment
26600 - Manufacture of irradiation, electromedical and electrotherapeutic equipment
32500 - Manufacture of medical and dental instruments and supplies
86220 - Specialists medical practice activities
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
31 / 12 | 31/12/2022 | 30/09/2024 |
Registered Office
C/O BUZZACOTT LLP
LONDON
EC2V 6DL
UNITED KINGDOM
This Company Originates in : United Kingdom
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
22/12/2023 | 05/01/2025 |
Map
UNITED KINGDOM
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
DR THOMAS LAMAR YEARWOOD | Sep 1950 | American | Director | 2019-12-23 | CURRENT |
DR STEPHEN PATRICK WARD | Mar 1967 | British | Director | 2022-04-01 | CURRENT |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Dr Thomas Lamar Yearwood | 2019-12-23 | 9/1950 | London |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
ACCOUNTS - Final Accounts preparation | 2023-10-18 | 31-12-2022 | -141,640 equity |
ACCOUNTS - Final Accounts preparation | 2022-07-28 | 31-12-2021 | -51,510 equity |